Grant RadarWorldwide funding

Browse grants Log in Get started

Health Opening SoonRFA-NS-26-031

Exposomic Contributions to ADRD Pathology and Resilience

National Institutes of Health opportunity RFA-NS-26-031

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthRFA-NS-26-031Grants.gov

Related Grants

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)

Amount not stated

20 Oct 2028(714d)

Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional

Amount not stated

Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)

Amount not stated

Centers of Excellence in Healthcare Quality and Safety

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Programme Details

Programme Code

RFA-NS-26-031